Details for New Drug Application (NDA): 218140
✉ Email this page to a colleague
NDA 218140 describes VANCOMYCIN HYDROCHLORIDE, which is a drug marketed by Abon Pharms Llc, Fresenius Kabi Usa, Lupin Ltd, Orient Pharma Co Ltd, Strides Pharma, Watson Labs, Alkem Labs Ltd, Amneal, Aspiro, Avet Lifesciences, Eugia Pharma, Gland, Hikma, Hikma Pharms, Hospira, Hospira Inc, Knack, Medimetriks Pharms, Meitheal, Mylan Labs Ltd, Plano Pharms, Sagent Pharms, Slate Run Pharma, Teva Pharms Usa, Xellia Pharms Aps, Steriscience, Zhejiang Novus Pharm, Samson Medcl, and Baxter Hlthcare, and is included in fifty-four NDAs. It is available from twenty-five suppliers. Additional details are available on the VANCOMYCIN HYDROCHLORIDE profile page.
The generic ingredient in VANCOMYCIN HYDROCHLORIDE is vancomycin hydrochloride. There are twenty-two drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the vancomycin hydrochloride profile page.
The generic ingredient in VANCOMYCIN HYDROCHLORIDE is vancomycin hydrochloride. There are twenty-two drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the vancomycin hydrochloride profile page.
Summary for 218140
| Tradename: | VANCOMYCIN HYDROCHLORIDE |
| Applicant: | Gland |
| Ingredient: | vancomycin hydrochloride |
| Patents: | 0 |
Suppliers and Packaging for NDA: 218140
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| VANCOMYCIN HYDROCHLORIDE | vancomycin hydrochloride | POWDER;INTRAVENOUS | 218140 | ANDA | Sagent Pharmaceuticals | 25021-147 | 25021-147-20 | 10 VIAL in 1 CARTON (25021-147-20) / 15 mL in 1 VIAL |
| VANCOMYCIN HYDROCHLORIDE | vancomycin hydrochloride | POWDER;INTRAVENOUS | 218140 | ANDA | Sagent Pharmaceuticals | 25021-148 | 25021-148-30 | 10 VIAL in 1 CARTON (25021-148-30) / 25 mL in 1 VIAL |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | EQ 750MG BASE/VIAL | ||||
| Approval Date: | Mar 21, 2025 | TE: | AP | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | EQ 1.25GM BASE/VIAL | ||||
| Approval Date: | Mar 21, 2025 | TE: | AP | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | EQ 1.5GM BASE/VIAL | ||||
| Approval Date: | Mar 21, 2025 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
